middle.news
Why Is Acrux Selling US Rights to Its Prilocaine/Lidocaine Cream Now?
9:35am on Friday 12th of December, 2025 AEDT
•
Healthcare
Read Story
Why Is Acrux Selling US Rights to Its Prilocaine/Lidocaine Cream Now?
9:35am on Friday 12th of December, 2025 AEDT
Key Points
Divestment of US rights for Prilocaine/Lidocaine cream
Sale price of US$550,000 to be received in December 2025
Product no longer materially contributes to Acrux’s portfolio
Proceeds earmarked for Hormone Replacement Therapy (HRT) development
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE